Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
These initiatives aim to improve access to healthcare for rare disease patients
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
Subscribe To Our Newsletter & Stay Updated
